| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Wentworth Kory James is a Chief Financial Officer at TRDA. Recent filings cover 0 purchases and 37 sales. Those positions are worth an estimated $838K at current prices.
Our model assigns Wentworth Kory James a middling insider score of 61/100, based on 28 past trades. Over a 12-month horizon, 48.1% of those trades were profitable, with an average 12-month return of +6.4%.
Wentworth Kory James's largest disclosed position is in TRDA as Chief Financial Officer, worth about $838K. The recent filings there lean toward selling, a net 128,816 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 2,500 | $12.95 | $32,375.00 | -2.1% | -45.4% | - | |
| Mar 10, 2026 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 16,477 | $13.01 | $214,378.56 | -11.9% | -52.6% | - | |
| Mar 4, 2026 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 7,988 | $12.25 | $97,892.14 | -5.5% | -46.9% | - | |
| Nov 21, 2025 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 8,910 | $9.98 | $88,931.60 | -7.5% | +12.9% | - | |
| Mar 17, 2025 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 1,784 | $10.67 | $19,035.28 | -1.6% | -31.5% | +16.5% | |
| Dec 2, 2024 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 6,000 | $19.99 | $119,948.30 | -7.5% | -44.2% | -51.5% | |
| Nov 11, 2024 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 8,637 | $19.98 | $172,562.08 | -10.5% | -35.3% | -61.3% | |
| Sep 9, 2024 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 3,195 | $14.97 | $47,832.35 | -4.0% | +43.2% | -65.8% | |
| Jul 8, 2024 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 1,758 | $14.95 | $26,282.10 | -2.1% | +9.2% | -52.7% | |
| Mar 6, 2024 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 4,086 | $12.31 | $50,285.18 | -5.2% | +23.5% | -15.9% |